Nov. 18, 2019 SAN RAMON, Calif.—CooperVision announced today it has received U.S. Food and Drug Administration (FDA) approval of its innovative MiSight®...
A new Harris Poll shows only a third of parents know what myopia is.
The OCULUS Myopia Master® is the world’s first device to combine all the important measurements for myopia management.
The combined operation will serve the growing myopia management market.
The agreement heralds the next step in Visioneering's accelerating global expansion.
CYPRESS is a multi-center, double-masked, randomized controlled pivotal clinical study.
ECPs can use the calculator to explain treatment options.
Construction has begun but the company hasn't announced a date for the move.
RMM circulates to more than 55,000 eye care professionals in the United States, Canada, and globally.
Jobson Medical Information will be the official North American media sponsor.
Treehouse Eyes is bringing its brand of myopia management into select primary care practices.
Five-year data from the world’s longest-running clinical trial of pediatric contact lens wear.